Dose-Response Curve
Also known as: Dose-effect curve, Concentration-response curve, DRC
Dose-Response Curve is a graphical representation of the relationship between the dose of a drug (or ligand concentration) and the magnitude of the biological effect it produces. This fundamental pharmacological tool reveals key drug properties including potency, efficacy, and therapeutic window.
Last updated: February 1, 2026
Anatomy of a Dose-Response Curve
The classic dose-response curve is sigmoidal (S-shaped):
Response (%)
100 | _______________
| /
75 | /
| /
50 |-------/-------- EC50
| /
25 | /
| /
0 |___/________________________
Low High
Dose (log scale)
Key Components
| Component | Description | What It Tells You |
|---|---|---|
| Baseline | Response at zero dose | Background effect level |
| Threshold | Minimum dose for effect | Where drug action begins |
| Linear region | Steep portion of curve | Dose-dependent response zone |
| EC50 | Dose at 50% max effect | Drug potency |
| Emax | Maximum plateau | Intrinsic efficacy |
Interpreting Curve Shape
Potency (Horizontal Position)
Curves shifted left indicate higher potency:
Response
| A B C
| / / /
| / / /
|__/____/____/______
Dose →
A = Most potent (lowest dose needed)
C = Least potent (highest dose needed)
Efficacy (Vertical Height)
Plateau height indicates maximum possible effect:
Response
High| _____ Full agonist
| /
| / ___ Partial agonist
| / /
|/_/_________
Dose →
Slope (Steepness)
- Steep slope: Narrow dose range between minimal and maximal effect
- Shallow slope: Wide dose range, more dosing flexibility
- Hill coefficient: Mathematical measure of steepness
Types of Dose-Response Relationships
Graded Response
Measures effect intensity in a single system:
- Muscle contraction force
- Hormone secretion rate
- Receptor binding percentage
Quantal Response
Measures proportion of population responding:
- ED50: Dose effective in 50% of subjects
- TD50: Dose toxic to 50% of subjects
- LD50: Dose lethal to 50% of subjects (animal studies)
Practical Applications
Comparing Drugs
| Drug | EC50 | Emax | Interpretation |
|---|---|---|---|
| Drug A | 1 nM | 100% | Potent, full agonist |
| Drug B | 10 nM | 100% | Less potent, full agonist |
| Drug C | 1 nM | 50% | Potent, partial agonist |
Therapeutic Window
Response
| Therapeutic Toxic
| effect effect
| / /
| / ___ /
| / __| |/
|____/__|_____|_____
↑___↑
Therapeutic
Window
A wide therapeutic window (large separation between therapeutic and toxic curves) indicates a safer drug.
Peptide-Specific Considerations
GLP-1 Agonists
Semaglutide dose-response for weight loss:
- Titration exploits the linear region
- Maximum doses approach Emax plateau
- Higher doses yield diminishing returns with more side effects
Growth Hormone Secretagogues
- Bell-shaped curves possible (inhibition at high doses)
- Receptor desensitization shifts curve right over time
- Pulsatile dosing maintains sensitivity
Frequently Asked Questions
Why are doses plotted on a log scale?
Drug effects typically span dose ranges of 100-fold or more. A logarithmic scale compresses this range, making the full curve visible and revealing the characteristic sigmoid shape that would appear as a sharp jump on a linear scale.
What does a flat dose-response curve mean?
A flat curve indicates no dose-dependent effect in that range. This could mean: doses are below threshold, doses are above Emax (plateau), the drug doesn’t affect that particular endpoint, or there’s a technical issue with the assay.
How do dose-response curves guide dosing decisions?
Optimal doses typically target the steep portion of the curve (responsive to dose adjustments) while avoiding the plateau (diminishing returns) and staying below toxic thresholds. Titration protocols are designed based on curve characteristics.
Related Peptides
Related Terms
Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.